Please login to the form below
The Medicines Company
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.
Cortellis Drugs to Watch in 2020 report
The three from this year’s list are: Valrox, which if approved, would become the first gene therapy for any form of haemophilia; Inclisiran, from The Medicines Company, which could become ... 8. Inclisiran from The Medicines Company (now a Novartis
Novartis plans inclisiran trial in the UK
The announcement was made on the same day that the company officially opened its new headquarters in White City, London. ... Novartis acquired inclisiran from The Medicines Company, after a completing a $9.7bn takeover of the company.
Cosentyx, Entresto drive topline growth for Novartis in Q4
According to the company, the momentum of the neprilysin inhibitor was driven by a higher demand in ambulatory settings. ... These new drugs are expected to continue to drive growth into 2020 – newly acquired cholesterol drug inclisiran, gained from
Novartis links up with NHS for speedy access to cholesterol drug inclisiran
Novartis gained inclisiran from its $9.7bn acquisition of the drug's developer The Medicines Company, which completed last week. ... watchdog NICE once it receives approval from the European Medicines Agency (EMA).
Novartis picks up inclisiran after completion of MedCo acquisition
If approved could become blockbuster cholesterol treatment. Novartis has added potential blockbuster cholesterol treatment inclisiran to its pipeline following the completion of its $9.7bn acquisition of The Medicines Company. . ... 2021. “Acquiring
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- Merck’s Keytruda hits the mark in triple negative breast cancer
- Finalists 2020 - Communiqué Awards
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Lilly starts world first trial of an antibody drug for COVID-19
- Pfizer’s Ibrance misses the mark in early breast cancer
- Rise of the patient influencer
- Working together against COVID-19
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
